EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study

Miriana d'Alessandro iD, Sara Gangi, Piera Soccio, Elisabet Cantó, Rubén Osuna-Gómez, Laura Bergantini iD, Paolo Cameli iD, Gaia Fabbri, Sara Croce, Giulia Scioscia iD, Giusy Montuori, Matteo Fanetti und 6 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24044071 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Miriana d'Alessandro und 17 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Diseases and Lung Transplantation Unit, Department of Medical and Surgical Sciences & Neuro-Sciences, University of Siena, 53100 Siena, I…. Hauptthemen laut MEDLINE: Bronchoalveolar Lavage Fluid, Extracellular Vesicles, Lung Diseases, Interstitial. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diagnosis of interstitial lung diseases (ILD) is difficult to perform. Extracellular vesicles (EVs) facilitate cell-to-cell communication, and they are released by a variety of cells. Our goal aimed to investigate EV markers in bronchoalveolar lavage (BAL) from idiopathic pulmonary fibrosis (IPF), sarcoidosis and hypersensitivity pneumonitis (HP) cohorts. ILD patients followed at Siena, Barcelona and Foggia University Hospitals were enrolled. BAL supernatants were used to isolate the EVs. They were characterized by flow cytometry assay through MACSPlex Exsome KIT. The majority of alveolar EV markers were related to the fibrotic damage. CD56, CD105, CD142, CD31 and CD49e were exclusively expressed by alveolar samples from IPF patients, while HP showed only CD86 and CD24. Some EV markers were common between HP and sarcoidosis (CD11c, CD1c, CD209, CD4, CD40, CD44, CD8). Principal component analysis distinguished the three groups based on EV markers with total variance of 60.08%. This study has demonstrated the validity of the flow cytometric method to phenotype and characterize EV surface markers in BAL samples. The two granulomatous diseases, sarcoidosis and HP, cohorts shared alveolar EV markers not revealed in IPF patients. Our findings demonstrated the viability of the alveolar compartment allowing identification of lung-specific markers for IPF and HP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchoalveolar Lavage FluidExtracellular VesiclesLung Diseases, InterstitialHumansAlveolitis, Extrinsic AllergicIdiopathic Pulmonary FibrosisSarcoidosisBiomarkers

Stichwörter der Autor:innen

bronchoalveolar lavagediagnosisextracellular vesiclesidiopathic pulmonary fibrosisinterstitial lung diseases

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Respiratory Diseases and Lung Transplantation Unit, Department of Medical and Surgical Sciences & Neuro-Sciences, University of Siena, 53100 Siena, Italy.
  • Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
  • Institute of Respiratory Diseases, Policlinico Riuniti of Foggia, 71122 Foggia, Italy.
  • Inflammatory Diseases, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.
  • Diagnostic and Interventional Bronchoscopy Unit, Cardio-Thoracic and Vascular Department, University Hospital of Siena (Azienda Ospedaliera Universitaria Senese-AOUS), 53100 Siena, Italy.
  • Respiratory Department, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute (IIB-Sant Pau), 08041 Barcelona, Spain.

ORCID-Profile: Miriana d'Alessandro, Laura Bergantini, Paolo Cameli, Giulia Scioscia, Giorgia Moriondo, Diego Castillo, Donato Lacedonia, Silvia Vidal

Zitieren

APA

d'Alessandro, M., Gangi, S., Soccio, P., Cantó, E., Osuna-Gómez, R., Bergantini, L., Cameli, P., Fabbri, G., Croce, S., Scioscia, G., Montuori, G., Fanetti, M., Moriondo, G., Mezzasalma, F., Castillo, D., Lacedonia, D., Vidal, S., & Bargagli, E. (2023). The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24044071

Vancouver

d'Alessandro M, Gangi S, Soccio P, Cantó E, Osuna-Gómez R, Bergantini L, et al. The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24044071

BibTeX
@article{dAlessandro2023,
  author = {d'Alessandro, Miriana and Gangi, Sara and Soccio, Piera and Cantó, Elisabet and Osuna-Gómez, Rubén and Bergantini, Laura and Cameli, Paolo and Fabbri, Gaia and Croce, Sara and Scioscia, Giulia and Montuori, Giusy and Fanetti, Matteo and Moriondo, Giorgia and Mezzasalma, Fabrizio and Castillo, Diego and Lacedonia, Donato and Vidal, Silvia and Bargagli, Elena},
  title = {The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24044071}
}
Kostenlos starten →